nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—Digestion impaired—Progesterone—uterine cancer	0.023	0.0241	CcSEcCtD
Ceftibuten—Digestion impaired—Medroxyprogesterone Acetate—uterine cancer	0.0208	0.0218	CcSEcCtD
Ceftibuten—Cholestasis—Progesterone—uterine cancer	0.0202	0.0212	CcSEcCtD
Ceftibuten—Vaginal inflammation—Progesterone—uterine cancer	0.0153	0.0161	CcSEcCtD
Ceftibuten—Eructation—Progesterone—uterine cancer	0.0151	0.0158	CcSEcCtD
Ceftibuten—Vaginal infection—Progesterone—uterine cancer	0.0145	0.0152	CcSEcCtD
Ceftibuten—Vaginal inflammation—Medroxyprogesterone Acetate—uterine cancer	0.0139	0.0146	CcSEcCtD
Ceftibuten—Nephropathy toxic—Etoposide—uterine cancer	0.0137	0.0144	CcSEcCtD
Ceftibuten—Vaginal infection—Medroxyprogesterone Acetate—uterine cancer	0.0131	0.0138	CcSEcCtD
Ceftibuten—Nasal congestion—Progesterone—uterine cancer	0.0122	0.0128	CcSEcCtD
Ceftibuten—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.0112	0.0117	CcSEcCtD
Ceftibuten—Irritability—Progesterone—uterine cancer	0.0106	0.0112	CcSEcCtD
Ceftibuten—Aplastic anaemia—Dactinomycin—uterine cancer	0.0102	0.0107	CcSEcCtD
Ceftibuten—Psychotic disorder—Medroxyprogesterone Acetate—uterine cancer	0.00986	0.0104	CcSEcCtD
Ceftibuten—Irritability—Medroxyprogesterone Acetate—uterine cancer	0.00963	0.0101	CcSEcCtD
Ceftibuten—Rigors—Etoposide—uterine cancer	0.00961	0.0101	CcSEcCtD
Ceftibuten—Dysuria—Progesterone—uterine cancer	0.009	0.00945	CcSEcCtD
Ceftibuten—Jaundice—Progesterone—uterine cancer	0.00837	0.00879	CcSEcCtD
Ceftibuten—Body temperature increased—Carboplatin—uterine cancer	0.00824	0.00865	CcSEcCtD
Ceftibuten—Dysuria—Medroxyprogesterone Acetate—uterine cancer	0.00816	0.00857	CcSEcCtD
Ceftibuten—Haemoglobin—Progesterone—uterine cancer	0.00774	0.00813	CcSEcCtD
Ceftibuten—Haemorrhage—Progesterone—uterine cancer	0.00771	0.00809	CcSEcCtD
Ceftibuten—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00758	0.00796	CcSEcCtD
Ceftibuten—Candida infection—Etoposide—uterine cancer	0.00749	0.00787	CcSEcCtD
Ceftibuten—Erythema multiforme—Progesterone—uterine cancer	0.00729	0.00765	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.00709	0.00744	CcSEcCtD
Ceftibuten—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.00702	0.00737	CcSEcCtD
Ceftibuten—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00698	0.00733	CcSEcCtD
Ceftibuten—Flatulence—Progesterone—uterine cancer	0.00661	0.00694	CcSEcCtD
Ceftibuten—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.0066	0.00693	CcSEcCtD
Ceftibuten—Pancytopenia—Dactinomycin—uterine cancer	0.00646	0.00679	CcSEcCtD
Ceftibuten—Neutropenia—Dactinomycin—uterine cancer	0.00636	0.00668	CcSEcCtD
Ceftibuten—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00627	0.00658	CcSEcCtD
Ceftibuten—SLC15A1—epithelium—uterine cancer	0.00618	0.13	CbGeAlD
Ceftibuten—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00602	0.00632	CcSEcCtD
Ceftibuten—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00599	0.00629	CcSEcCtD
Ceftibuten—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00595	0.00625	CcSEcCtD
Ceftibuten—Convulsion—Progesterone—uterine cancer	0.00581	0.0061	CcSEcCtD
Ceftibuten—SLC15A1—renal system—uterine cancer	0.00573	0.12	CbGeAlD
Ceftibuten—Agranulocytosis—Dactinomycin—uterine cancer	0.00566	0.00594	CcSEcCtD
Ceftibuten—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00559	0.00587	CcSEcCtD
Ceftibuten—Dry mouth—Progesterone—uterine cancer	0.00559	0.00586	CcSEcCtD
Ceftibuten—SLC15A1—endometrium—uterine cancer	0.00554	0.116	CbGeAlD
Ceftibuten—Anaphylactic shock—Progesterone—uterine cancer	0.00547	0.00575	CcSEcCtD
Ceftibuten—Rigors—Epirubicin—uterine cancer	0.00539	0.00566	CcSEcCtD
Ceftibuten—SLC15A1—mammalian vulva—uterine cancer	0.00536	0.113	CbGeAlD
Ceftibuten—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00527	0.00553	CcSEcCtD
Ceftibuten—Anorexia—Progesterone—uterine cancer	0.00522	0.00548	CcSEcCtD
Ceftibuten—Erythema multiforme—Dactinomycin—uterine cancer	0.00515	0.00541	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00513	0.00539	CcSEcCtD
Ceftibuten—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00506	0.00531	CcSEcCtD
Ceftibuten—Rigors—Doxorubicin—uterine cancer	0.00499	0.00524	CcSEcCtD
Ceftibuten—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00496	0.00521	CcSEcCtD
Ceftibuten—Insomnia—Progesterone—uterine cancer	0.00495	0.0052	CcSEcCtD
Ceftibuten—Paraesthesia—Progesterone—uterine cancer	0.00492	0.00516	CcSEcCtD
Ceftibuten—Chills—Dactinomycin—uterine cancer	0.00489	0.00513	CcSEcCtD
Ceftibuten—Dyspnoea—Progesterone—uterine cancer	0.00488	0.00512	CcSEcCtD
Ceftibuten—Somnolence—Progesterone—uterine cancer	0.00487	0.00511	CcSEcCtD
Ceftibuten—Dyspepsia—Progesterone—uterine cancer	0.00482	0.00506	CcSEcCtD
Ceftibuten—Decreased appetite—Progesterone—uterine cancer	0.00476	0.005	CcSEcCtD
Ceftibuten—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00473	0.00497	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Progesterone—uterine cancer	0.00473	0.00496	CcSEcCtD
Ceftibuten—Fatigue—Progesterone—uterine cancer	0.00472	0.00496	CcSEcCtD
Ceftibuten—Constipation—Progesterone—uterine cancer	0.00468	0.00492	CcSEcCtD
Ceftibuten—Pancytopenia—Etoposide—uterine cancer	0.00468	0.00491	CcSEcCtD
Ceftibuten—Neutropenia—Etoposide—uterine cancer	0.00461	0.00484	CcSEcCtD
Ceftibuten—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00449	0.00471	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Progesterone—uterine cancer	0.00448	0.0047	CcSEcCtD
Ceftibuten—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00445	0.00468	CcSEcCtD
Ceftibuten—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00442	0.00464	CcSEcCtD
Ceftibuten—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00441	0.00463	CcSEcCtD
Ceftibuten—Vaginal inflammation—Epirubicin—uterine cancer	0.0044	0.00462	CcSEcCtD
Ceftibuten—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00437	0.00459	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00435	0.00457	CcSEcCtD
Ceftibuten—Urticaria—Progesterone—uterine cancer	0.00435	0.00457	CcSEcCtD
Ceftibuten—Body temperature increased—Progesterone—uterine cancer	0.00433	0.00454	CcSEcCtD
Ceftibuten—Abdominal pain—Progesterone—uterine cancer	0.00433	0.00454	CcSEcCtD
Ceftibuten—Eructation—Epirubicin—uterine cancer	0.00432	0.00454	CcSEcCtD
Ceftibuten—Renal failure—Etoposide—uterine cancer	0.00432	0.00453	CcSEcCtD
Ceftibuten—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00431	0.00453	CcSEcCtD
Ceftibuten—Melaena—Epirubicin—uterine cancer	0.0043	0.00451	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00428	0.0045	CcSEcCtD
Ceftibuten—Jaundice—Etoposide—uterine cancer	0.00428	0.00449	CcSEcCtD
Ceftibuten—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00428	0.00449	CcSEcCtD
Ceftibuten—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00424	0.00445	CcSEcCtD
Ceftibuten—Candida infection—Epirubicin—uterine cancer	0.0042	0.00441	CcSEcCtD
Ceftibuten—Vaginal infection—Epirubicin—uterine cancer	0.00415	0.00436	CcSEcCtD
Ceftibuten—SLC15A1—vagina—uterine cancer	0.00415	0.0872	CbGeAlD
Ceftibuten—Aplastic anaemia—Epirubicin—uterine cancer	0.00413	0.00434	CcSEcCtD
Ceftibuten—Agranulocytosis—Etoposide—uterine cancer	0.0041	0.0043	CcSEcCtD
Ceftibuten—Vaginal inflammation—Doxorubicin—uterine cancer	0.00407	0.00428	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00406	0.00426	CcSEcCtD
Ceftibuten—Hypersensitivity—Progesterone—uterine cancer	0.00403	0.00424	CcSEcCtD
Ceftibuten—Eructation—Doxorubicin—uterine cancer	0.004	0.0042	CcSEcCtD
Ceftibuten—Melaena—Doxorubicin—uterine cancer	0.00398	0.00418	CcSEcCtD
Ceftibuten—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00394	0.00414	CcSEcCtD
Ceftibuten—Asthenia—Progesterone—uterine cancer	0.00393	0.00412	CcSEcCtD
Ceftibuten—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00392	0.00412	CcSEcCtD
Ceftibuten—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00392	0.00412	CcSEcCtD
Ceftibuten—Candida infection—Doxorubicin—uterine cancer	0.00389	0.00408	CcSEcCtD
Ceftibuten—Pruritus—Progesterone—uterine cancer	0.00387	0.00407	CcSEcCtD
Ceftibuten—Vaginal infection—Doxorubicin—uterine cancer	0.00384	0.00404	CcSEcCtD
Ceftibuten—SLC15A2—uterine cervix—uterine cancer	0.00383	0.0805	CbGeAlD
Ceftibuten—Aplastic anaemia—Doxorubicin—uterine cancer	0.00382	0.00401	CcSEcCtD
Ceftibuten—Diarrhoea—Progesterone—uterine cancer	0.00375	0.00393	CcSEcCtD
Ceftibuten—Erythema multiforme—Etoposide—uterine cancer	0.00373	0.00391	CcSEcCtD
Ceftibuten—Anorexia—Dactinomycin—uterine cancer	0.00369	0.00387	CcSEcCtD
Ceftibuten—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00365	0.00384	CcSEcCtD
Ceftibuten—Dizziness—Progesterone—uterine cancer	0.00362	0.0038	CcSEcCtD
Ceftibuten—SLC15A2—renal system—uterine cancer	0.00358	0.0753	CbGeAlD
Ceftibuten—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00356	0.00374	CcSEcCtD
Ceftibuten—Chills—Etoposide—uterine cancer	0.00354	0.00371	CcSEcCtD
Ceftibuten—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00351	0.00369	CcSEcCtD
Ceftibuten—Vomiting—Progesterone—uterine cancer	0.00348	0.00365	CcSEcCtD
Ceftibuten—SLC15A2—endometrium—uterine cancer	0.00347	0.0728	CbGeAlD
Ceftibuten—Rash—Progesterone—uterine cancer	0.00345	0.00362	CcSEcCtD
Ceftibuten—Dermatitis—Progesterone—uterine cancer	0.00345	0.00362	CcSEcCtD
Ceftibuten—Headache—Progesterone—uterine cancer	0.00343	0.0036	CcSEcCtD
Ceftibuten—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00339	0.00356	CcSEcCtD
Ceftibuten—Decreased appetite—Dactinomycin—uterine cancer	0.00336	0.00353	CcSEcCtD
Ceftibuten—Dysgeusia—Etoposide—uterine cancer	0.00336	0.00353	CcSEcCtD
Ceftibuten—Renal impairment—Epirubicin—uterine cancer	0.00336	0.00352	CcSEcCtD
Ceftibuten—Fatigue—Dactinomycin—uterine cancer	0.00334	0.0035	CcSEcCtD
Ceftibuten—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00328	0.00344	CcSEcCtD
Ceftibuten—Nausea—Progesterone—uterine cancer	0.00325	0.00341	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00316	0.00332	CcSEcCtD
Ceftibuten—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00315	0.00331	CcSEcCtD
Ceftibuten—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00313	0.00328	CcSEcCtD
Ceftibuten—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00313	0.00328	CcSEcCtD
Ceftibuten—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00311	0.00326	CcSEcCtD
Ceftibuten—Renal impairment—Doxorubicin—uterine cancer	0.00311	0.00326	CcSEcCtD
Ceftibuten—Body temperature increased—Dactinomycin—uterine cancer	0.00306	0.00321	CcSEcCtD
Ceftibuten—Abdominal pain—Dactinomycin—uterine cancer	0.00306	0.00321	CcSEcCtD
Ceftibuten—Convulsion—Etoposide—uterine cancer	0.00297	0.00312	CcSEcCtD
Ceftibuten—Dehydration—Epirubicin—uterine cancer	0.00297	0.00312	CcSEcCtD
Ceftibuten—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00295	0.00309	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00288	0.00302	CcSEcCtD
Ceftibuten—SLC15A2—female reproductive system—uterine cancer	0.00287	0.0603	CbGeAlD
Ceftibuten—Hypersensitivity—Dactinomycin—uterine cancer	0.00285	0.00299	CcSEcCtD
Ceftibuten—Anaphylactic shock—Etoposide—uterine cancer	0.0028	0.00294	CcSEcCtD
Ceftibuten—Asthenia—Dactinomycin—uterine cancer	0.00278	0.00292	CcSEcCtD
Ceftibuten—Dehydration—Doxorubicin—uterine cancer	0.00275	0.00289	CcSEcCtD
Ceftibuten—Anorexia—Etoposide—uterine cancer	0.00267	0.0028	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00266	0.00279	CcSEcCtD
Ceftibuten—Diarrhoea—Dactinomycin—uterine cancer	0.00265	0.00278	CcSEcCtD
Ceftibuten—Pancytopenia—Epirubicin—uterine cancer	0.00262	0.00275	CcSEcCtD
Ceftibuten—SLC15A2—female gonad—uterine cancer	0.00261	0.0548	CbGeAlD
Ceftibuten—SLC15A2—vagina—uterine cancer	0.0026	0.0545	CbGeAlD
Ceftibuten—Dysuria—Epirubicin—uterine cancer	0.00258	0.00271	CcSEcCtD
Ceftibuten—Neutropenia—Epirubicin—uterine cancer	0.00258	0.00271	CcSEcCtD
Ceftibuten—Paraesthesia—Etoposide—uterine cancer	0.00251	0.00264	CcSEcCtD
Ceftibuten—Dyspnoea—Etoposide—uterine cancer	0.0025	0.00262	CcSEcCtD
Ceftibuten—Somnolence—Etoposide—uterine cancer	0.00249	0.00261	CcSEcCtD
Ceftibuten—Vomiting—Dactinomycin—uterine cancer	0.00246	0.00258	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00244	0.00256	CcSEcCtD
Ceftibuten—Rash—Dactinomycin—uterine cancer	0.00244	0.00256	CcSEcCtD
Ceftibuten—Decreased appetite—Etoposide—uterine cancer	0.00243	0.00256	CcSEcCtD
Ceftibuten—Pancytopenia—Doxorubicin—uterine cancer	0.00243	0.00255	CcSEcCtD
Ceftibuten—Renal failure—Epirubicin—uterine cancer	0.00242	0.00254	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Etoposide—uterine cancer	0.00242	0.00254	CcSEcCtD
Ceftibuten—Fatigue—Etoposide—uterine cancer	0.00241	0.00254	CcSEcCtD
Ceftibuten—Jaundice—Epirubicin—uterine cancer	0.0024	0.00252	CcSEcCtD
Ceftibuten—Constipation—Etoposide—uterine cancer	0.00239	0.00251	CcSEcCtD
Ceftibuten—Neutropenia—Doxorubicin—uterine cancer	0.00239	0.00251	CcSEcCtD
Ceftibuten—Dysuria—Doxorubicin—uterine cancer	0.00239	0.00251	CcSEcCtD
Ceftibuten—Haematuria—Epirubicin—uterine cancer	0.00235	0.00246	CcSEcCtD
Ceftibuten—Nausea—Dactinomycin—uterine cancer	0.0023	0.00241	CcSEcCtD
Ceftibuten—Agranulocytosis—Epirubicin—uterine cancer	0.0023	0.00241	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Etoposide—uterine cancer	0.00229	0.0024	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00226	0.00237	CcSEcCtD
Ceftibuten—Renal failure—Doxorubicin—uterine cancer	0.00224	0.00235	CcSEcCtD
Ceftibuten—Urticaria—Etoposide—uterine cancer	0.00222	0.00234	CcSEcCtD
Ceftibuten—Haemoglobin—Epirubicin—uterine cancer	0.00222	0.00233	CcSEcCtD
Ceftibuten—Jaundice—Doxorubicin—uterine cancer	0.00222	0.00233	CcSEcCtD
Ceftibuten—Body temperature increased—Etoposide—uterine cancer	0.00221	0.00232	CcSEcCtD
Ceftibuten—Abdominal pain—Etoposide—uterine cancer	0.00221	0.00232	CcSEcCtD
Ceftibuten—Haemorrhage—Epirubicin—uterine cancer	0.00221	0.00232	CcSEcCtD
Ceftibuten—Haematuria—Doxorubicin—uterine cancer	0.00217	0.00228	CcSEcCtD
Ceftibuten—Agranulocytosis—Doxorubicin—uterine cancer	0.00213	0.00223	CcSEcCtD
Ceftibuten—Erythema multiforme—Epirubicin—uterine cancer	0.00209	0.00219	CcSEcCtD
Ceftibuten—Hypersensitivity—Etoposide—uterine cancer	0.00206	0.00217	CcSEcCtD
Ceftibuten—Haemoglobin—Doxorubicin—uterine cancer	0.00205	0.00216	CcSEcCtD
Ceftibuten—Haemorrhage—Doxorubicin—uterine cancer	0.00204	0.00215	CcSEcCtD
Ceftibuten—Asthenia—Etoposide—uterine cancer	0.00201	0.00211	CcSEcCtD
Ceftibuten—Chills—Epirubicin—uterine cancer	0.00198	0.00208	CcSEcCtD
Ceftibuten—Pruritus—Etoposide—uterine cancer	0.00198	0.00208	CcSEcCtD
Ceftibuten—Erythema multiforme—Doxorubicin—uterine cancer	0.00193	0.00203	CcSEcCtD
Ceftibuten—Diarrhoea—Etoposide—uterine cancer	0.00192	0.00201	CcSEcCtD
Ceftibuten—Flatulence—Epirubicin—uterine cancer	0.0019	0.00199	CcSEcCtD
Ceftibuten—Dysgeusia—Epirubicin—uterine cancer	0.00188	0.00198	CcSEcCtD
Ceftibuten—Dizziness—Etoposide—uterine cancer	0.00185	0.00194	CcSEcCtD
Ceftibuten—Chills—Doxorubicin—uterine cancer	0.00183	0.00193	CcSEcCtD
Ceftibuten—Vomiting—Etoposide—uterine cancer	0.00178	0.00187	CcSEcCtD
Ceftibuten—Agitation—Epirubicin—uterine cancer	0.00177	0.00186	CcSEcCtD
Ceftibuten—Rash—Etoposide—uterine cancer	0.00177	0.00185	CcSEcCtD
Ceftibuten—Dermatitis—Etoposide—uterine cancer	0.00176	0.00185	CcSEcCtD
Ceftibuten—Headache—Etoposide—uterine cancer	0.00175	0.00184	CcSEcCtD
Ceftibuten—Flatulence—Doxorubicin—uterine cancer	0.00175	0.00184	CcSEcCtD
Ceftibuten—Dysgeusia—Doxorubicin—uterine cancer	0.00174	0.00183	CcSEcCtD
Ceftibuten—SLC15A2—lymph node—uterine cancer	0.00168	0.0353	CbGeAlD
Ceftibuten—Convulsion—Epirubicin—uterine cancer	0.00167	0.00175	CcSEcCtD
Ceftibuten—Nausea—Etoposide—uterine cancer	0.00166	0.00175	CcSEcCtD
Ceftibuten—Agitation—Doxorubicin—uterine cancer	0.00164	0.00172	CcSEcCtD
Ceftibuten—Dry mouth—Epirubicin—uterine cancer	0.0016	0.00168	CcSEcCtD
Ceftibuten—Anaphylactic shock—Epirubicin—uterine cancer	0.00157	0.00165	CcSEcCtD
Ceftibuten—Convulsion—Doxorubicin—uterine cancer	0.00154	0.00162	CcSEcCtD
Ceftibuten—Anorexia—Epirubicin—uterine cancer	0.0015	0.00157	CcSEcCtD
Ceftibuten—Dry mouth—Doxorubicin—uterine cancer	0.00148	0.00156	CcSEcCtD
Ceftibuten—Anaphylactic shock—Doxorubicin—uterine cancer	0.00145	0.00153	CcSEcCtD
Ceftibuten—Insomnia—Epirubicin—uterine cancer	0.00142	0.00149	CcSEcCtD
Ceftibuten—Paraesthesia—Epirubicin—uterine cancer	0.00141	0.00148	CcSEcCtD
Ceftibuten—Dyspnoea—Epirubicin—uterine cancer	0.0014	0.00147	CcSEcCtD
Ceftibuten—Somnolence—Epirubicin—uterine cancer	0.0014	0.00147	CcSEcCtD
Ceftibuten—Anorexia—Doxorubicin—uterine cancer	0.00138	0.00145	CcSEcCtD
Ceftibuten—Dyspepsia—Epirubicin—uterine cancer	0.00138	0.00145	CcSEcCtD
Ceftibuten—Decreased appetite—Epirubicin—uterine cancer	0.00136	0.00143	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Epirubicin—uterine cancer	0.00136	0.00142	CcSEcCtD
Ceftibuten—Fatigue—Epirubicin—uterine cancer	0.00135	0.00142	CcSEcCtD
Ceftibuten—Constipation—Epirubicin—uterine cancer	0.00134	0.00141	CcSEcCtD
Ceftibuten—Insomnia—Doxorubicin—uterine cancer	0.00131	0.00138	CcSEcCtD
Ceftibuten—Paraesthesia—Doxorubicin—uterine cancer	0.0013	0.00137	CcSEcCtD
Ceftibuten—Dyspnoea—Doxorubicin—uterine cancer	0.0013	0.00136	CcSEcCtD
Ceftibuten—Somnolence—Doxorubicin—uterine cancer	0.00129	0.00136	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Epirubicin—uterine cancer	0.00128	0.00135	CcSEcCtD
Ceftibuten—Dyspepsia—Doxorubicin—uterine cancer	0.00128	0.00134	CcSEcCtD
Ceftibuten—Decreased appetite—Doxorubicin—uterine cancer	0.00126	0.00133	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.00125	0.00132	CcSEcCtD
Ceftibuten—Fatigue—Doxorubicin—uterine cancer	0.00125	0.00131	CcSEcCtD
Ceftibuten—Urticaria—Epirubicin—uterine cancer	0.00125	0.00131	CcSEcCtD
Ceftibuten—Constipation—Doxorubicin—uterine cancer	0.00124	0.0013	CcSEcCtD
Ceftibuten—Abdominal pain—Epirubicin—uterine cancer	0.00124	0.0013	CcSEcCtD
Ceftibuten—Body temperature increased—Epirubicin—uterine cancer	0.00124	0.0013	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00119	0.00125	CcSEcCtD
Ceftibuten—Hypersensitivity—Epirubicin—uterine cancer	0.00116	0.00121	CcSEcCtD
Ceftibuten—Urticaria—Doxorubicin—uterine cancer	0.00115	0.00121	CcSEcCtD
Ceftibuten—Abdominal pain—Doxorubicin—uterine cancer	0.00115	0.00121	CcSEcCtD
Ceftibuten—Body temperature increased—Doxorubicin—uterine cancer	0.00115	0.00121	CcSEcCtD
Ceftibuten—Asthenia—Epirubicin—uterine cancer	0.00113	0.00118	CcSEcCtD
Ceftibuten—Pruritus—Epirubicin—uterine cancer	0.00111	0.00117	CcSEcCtD
Ceftibuten—Diarrhoea—Epirubicin—uterine cancer	0.00107	0.00113	CcSEcCtD
Ceftibuten—Hypersensitivity—Doxorubicin—uterine cancer	0.00107	0.00112	CcSEcCtD
Ceftibuten—Asthenia—Doxorubicin—uterine cancer	0.00104	0.00109	CcSEcCtD
Ceftibuten—Dizziness—Epirubicin—uterine cancer	0.00104	0.00109	CcSEcCtD
Ceftibuten—Pruritus—Doxorubicin—uterine cancer	0.00103	0.00108	CcSEcCtD
Ceftibuten—Vomiting—Epirubicin—uterine cancer	0.000998	0.00105	CcSEcCtD
Ceftibuten—Diarrhoea—Doxorubicin—uterine cancer	0.000994	0.00104	CcSEcCtD
Ceftibuten—Rash—Epirubicin—uterine cancer	0.00099	0.00104	CcSEcCtD
Ceftibuten—Dermatitis—Epirubicin—uterine cancer	0.000989	0.00104	CcSEcCtD
Ceftibuten—Headache—Epirubicin—uterine cancer	0.000983	0.00103	CcSEcCtD
Ceftibuten—Dizziness—Doxorubicin—uterine cancer	0.000961	0.00101	CcSEcCtD
Ceftibuten—Nausea—Epirubicin—uterine cancer	0.000932	0.000979	CcSEcCtD
Ceftibuten—Vomiting—Doxorubicin—uterine cancer	0.000924	0.00097	CcSEcCtD
Ceftibuten—Rash—Doxorubicin—uterine cancer	0.000916	0.000962	CcSEcCtD
Ceftibuten—Dermatitis—Doxorubicin—uterine cancer	0.000915	0.000961	CcSEcCtD
Ceftibuten—Headache—Doxorubicin—uterine cancer	0.00091	0.000955	CcSEcCtD
Ceftibuten—Nausea—Doxorubicin—uterine cancer	0.000863	0.000906	CcSEcCtD
